In addition, cytoprotective effects of overexpressed PrxIV were evident in nongenetic mouse models of both type 1 and type 2 diabetes mellitus (T1DM and T2DM) [104, 105]. Here, PRDX4 is linked to type 2 diabetes mellitus.